Friday, December 13, 2019 11:36:21 PM
The FDA really put a hamper on USRM's plans. Prior to the injunction, it seemed USRM's revenues were going solidly up. USRM once had a lot of potential. I don't see management really "reinventing" USRM nor do I at this point of time see a "Plan-B".
I haven't sold a share however I do think USRM might eventually become a tax write-off.
Oh well.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM